Related Experiment Video
Updated: Jun 16, 2026

Live Cell Imaging to Assess the Dynamics of Metaphase Timing and Cell Fate Following Mitotic Spindle Perturbations
Published on: September 20, 2019
Centrosome amplification as a possible marker of mitotic disruptions and cellular carcinogenesis in multiple myeloma
E Dementyeva1, P Nemec, F Kryukov
1University Research Centre, Czech Myeloma Group, Babak Research Institute, Masaryk University, Brno, Czech Republic.
Abstract:
Centrosome amplification (CA) as a potential marker of mitotic disruptions in multiple myeloma (MM) was investigated in two populations of B-cell lineage: B-cells and plasma cells (PCs). Using immunofluorescent staining, it was shown that CA in B-cells is present in 3.2+/-2.5% in healthy donors versus 9.9+/-7.9% in MM patients (p<0.0001). Based on the calculated threshold value of CA in B-cells, 37% (14/38) of MM patients were positive. There was no significant correlation between CA-positive MM cases (based on PC samples evaluation) and the occurrence of cytogenetic abnormalities in PCs, including del(13)(q14), del(17)(p13), gain(1)(q21) and hyperdiploidy.
Related Concept Videos
Centrosome Duplication
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...
Centrosome Duplication
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...
Destabilization of Microtubules
Centrioles and Centrosomes
Near the end of the prophase, also called late prophase or "prometaphase,"...
Induced Pluripotent Stem Cells
Somatic cells are...
Anaphase Promoting Complex

